Kronos Worldwide, a leading producer of titanium dioxide, announced it expects to report its third quarter 2026 earnings on November 5, 2026, after the market closes. This announcement signals when investors can anticipate updated financial results following the completion of quarter-end closing procedures. The company’s prior quarterly updates included a regular dividend declaration and second quarter earnings report, providing context for ongoing financial performance. Investors will be watching the upcoming report for insights into Kronos Worldwide's recent business trends and profitability.
Kronos Worldwide's upcoming third quarter 2026 earnings release date is announced for November 5, 2026. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Oct 15, 2026 03:23 WIB: out of 83 priced US stocks, 16 rose and 67 fell. Notable movers include AUGO at USD 82.05 with a -6.70% change, AG at USD 15.26 with -6.55%, and IAG at USD 17.10 with -6.40%.
Stephany Insurance LLC, a fourth-generation independent agency in Wexford, PA, is highlighted in a new 2026 guide for helping small businesses in Pittsburgh's North Hills identify and close insurance coverage gaps caused by rising premiums. The guide...
The Knowles-Rowland House, a $13.96 million redevelopment project by Bread of Life Inc., has opened in Midtown Houston, providing 31 permanent supportive housing units for individuals exiting chronic homelessness. The building, formerly a fire-damage...
ATLAS SP Partners, majority owned by Apollo funds, announced the pricing of $750 million senior notes due 2032 with a fixed 6.25% interest rate until November 2031, then switching to a floating rate based on SOFR plus a spread. The notes, issued by A...
Bending Spoons led market gainers with a 41.2% rise after Berkshire Hathaway increased its stake to 4% by investing an additional $330 million. Antelope Enterprise gained 36.4%, and NEXGEL rose 32.1% following a reverse stock split. Liquidia advanced...
The Law Offices of Frank R. Cruz is investigating Alignment Healthcare following a whistleblower lawsuit claiming the company misclassified $8-10 million in expenses to inflate its adjusted EBITDA and stock price. This alleged accounting manipulation...
